Which is better, JNJ or SLNO?

On the Buffett-Fit framework, Johnson & Johnson (JNJ) currently grades higher than SLNO, 60/100 (C grade) vs 50/100 (C). That said, "better" depends on which framework you trust, JNJ wins on Warren Buffett, Benjamin Graham, Philip Fisher, Peter Lynch, Charlie Munger, and Terry Smith; SLNO wins on none. The full pillar breakdown is on this page.

Should I buy JNJ or SLNO?

This page is an educational comparison, not investment advice. Both JNJ and SLNO are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most, and always do your own research before making any investment decision.

Is JNJ better than SLNO for value investing?

On the Buffett-style value-investing framework, JNJ currently grades higher, 60/100 vs 50/100, a 10-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between JNJ and SLNO on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). JNJ currently scores 60/100; SLNO scores 50/100. The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, JNJ or SLNO?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. JNJ and SLNO are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, JNJ or SLNO?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are JNJ and SLNO both Healthcare stocks?

Yes: both Johnson & Johnson (JNJ) and Soleno Therapeutics, Inc. (SLNO) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this JNJ vs SLNO comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria: they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Johnson & Johnson

JNJ$611.9BHealthcare Market cap, Sector

Soleno Therapeutics

SLNO-Healthcare Market cap, Sector

Overall winner

Johnson & Johnson

JNJ 60 SLNO

Fit scores by strategy

JNJ6wins

0winsSLNO

Warren Buffett

60C

D50

Benjamin Graham

67C

D50

Philip Fisher

63C

D50

Peter Lynch

52D

D50

Joel Greenblatt

50D

D50

Charlie Munger

64C

D50

Terry Smith

58D

D50

Side-by-side metrics

Metric	JNJ	SLNO
Market cap	$611.9B	-
P/E (TTM)	22.2x	-
EV/EBIT	18.6x	-
ROIC (TTM)	20.99%	-
Gross margin

More like JNJ

JNJ vs LLY JNJ vs ABBV JNJ vs RO.SW JNJ vs UNH

More like SLNO

SLNO vs LLY SLNO vs ABBV

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

For education only. Fit scores apply each investor's published criteria to public financial data. They are not personal recommendations.

See the full analysis of Johnson & Johnson vs Soleno Therapeutics

The score, the checklist and the full reasoning open with a free account. You get 3 full analyses a week, and this stock is the first one. No card needed.

Create a free account

3 full analyses a week · no card needed

Already have an account? Sign in

JNJ vs SLNO: 60/100 vs 50/100 on Buffett-Fit · invest-like

See the full analysis of Johnson & Johnson vs Soleno Therapeutics

Key terms in this analysis